Irnozen 20 mg Injection
$48.49
$37.83
Irnozen 20 mg Injection is an effective topoisomerase inhibitor designed for the treatment of advanced colorectal cancer, offering hope to patients battling this challenging disease. This medication can be utilized alone or in conjunction with other therapies, such as 5-fluorouracil and folinic acid, particularly for individuals who have not undergone prior chemotherapy for advanced cancer. By interfering with the DNA replication process, Irnozen helps to hinder the growth of cancer cells, making it a vital option in the first-line treatment of metastatic carcinoma of the colon or rectum. It is essential for patients to discuss their medical history and potential drug interactions with their healthcare provider, as certain warnings and precautions may apply. Regular monitoring during treatment is crucial to manage any possible side effects effectively. With its targeted action, Irnozen 20 mg Injection represents a significant advancement in the therapeutic landscape for colorectal cancer, enhancing treatment options for patients. Always consult a healthcare professional to ensure that this treatment aligns with your specific medical needs and conditions.
Quantity
Active Pharmaceutical Ingredient
Uses
• Irnozen 20 mg injection is primarily used in cancer treatment protocols, specifically as part of a combination chemotherapy regimen. This medication is administered intravenously by qualified healthcare professionals in clinical settings. The use of Irnozen helps to target and inhibit cancer cell growth, making it a critical component in managing various cancer types. Treatment plans involving Irnozen are tailored to meet the specific needs of each patient based on their unique medical circumstances.
• In clinical practice, Irnozen 20 mg injection is often employed for patients undergoing intensive cancer therapies. The administration of this injection is typically managed by doctors or nurses who monitor the patient's response closely. By using Irnozen, healthcare providers aim to enhance the overall effectiveness of the chemotherapy regimen. This targeted approach helps to maximize the potential benefits while considering the individual’s treatment goals.
• Irnozen 20 mg injection can play a vital role in the management of advanced cancer stages. Its intravenous delivery ensures rapid absorption and effectiveness in combating aggressive cancer cells. This medication is frequently used in conjunction with other agents to improve patient outcomes. As part of a comprehensive treatment strategy, Irnozen helps to provide a more robust defense against the progression of cancer.
• The use of Irnozen 20 mg injection is a key aspect of personalized cancer therapy. Healthcare providers assess various factors, including cancer type and patient health, to determine the most effective use of this medication. By integrating Irnozen into a chemotherapy regimen, doctors strive to optimize treatment efficacy and patient well-being. This approach underscores the importance of tailored therapies in modern oncology.
Benefits
Treatment of colon and rectum cancer: Cancer of the colon and rectum, also known as colorectal cancer (CRC) or bowel cancer, is the development of cancer from two parts of the large intestine, namely, the colon or rectum. In this type of cancer, the person may notice symptoms such as blood in the stool, a change in bowel movements, weight loss, and fatigue. Irnozen 20 mg Injection treats and also lowers the risk of developing further cancerous growths (polyps) and bowel cancer. It kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is an effective, yet very toxic medicine and you should discuss the risks and benefits with your doctor. Avoid drinking alcohol or smoking while having this treatment and drink plenty of water to stay hydrated.
Side Effects
Like all medications, Irnozen 20 mg Injection can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects
• Nausea
• Vomiting
• Constipation
• Fever
• Infection
• Pain
Common Side Effects
• Diarrhea
• Kidney Impairment
• Lung Problems
• Low blood count
How To Use
Irnozen 20 mg Injection is administered by a qualified doctor or nurse at a hospital or clinical setting. It is given intravenously and is usually given as part of a combination chemotherapy regimen. The specific treatment plan and dosage will depend on the type and stage of the cancer being treated, as well as other individual factors determined by the healthcare provider.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Irnozen 20 mg Injection. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Irnozen 20 mg Injection should be used with caution in patients with kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Irnozen 20 mg and report any unusual symptoms or changes in kidney function to their doctor. Irnozen 20 mg Injection is not recommended for use in patients on dialysis.
• Breastfeeding: The available data are limited but suggested that Irnozen 20 mg Injection and its metabolite are excreted in human milk. Consequently, because of the potential for adverse reactions in nursing infants, breastfeeding should be discontinued for the duration of Irnozen 20 mg therapy.
• Liver: Irnozen 20 mg Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Irnozen 20 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Irnozen 20 mg Injection may need to be adjusted in patients with liver disease.
• Pregnancy: There are limited data on the use of irinotecan in pregnant women. Irnozen 20 mg Injection has been shown to be embryotoxic and teratogenic in animals. Therefore, based on results from animal studies and the mechanism of action of Irnozen 20 mg, Irnozen 20 mg Injection should not be used during pregnancy unless clearly necessary. Women of childbearing potential should not be started on Irnozen 20 mg Injection until pregnancy is excluded. Pregnancy should be avoided if either partner is receiving Irnozen 20 mg Injection.
• Driving: Irnozen 20 mg Injection has a moderate influence on the ability to drive and use machines. Patients should be warned about the potential for dizziness or visual disturbances which may occur within 24 hours following the administration of Irnozen 20 mg and advised not to drive or operate machinery if these symptoms occur.